ALX Oncology Holdings Inc.ALXONASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank57
3Y CAGR-6.3%
5Y CAGR+10.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-6.3%/yr
vs +82.8%/yr prior
5Y CAGR
+10.0%/yr
Recent deceleration
Acceleration
-89.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$23.85M-8.6%
2024$26.09M-8.4%
2023$28.48M-1.9%
2022$29.04M+24.2%
2021$23.39M+57.9%
2020$14.81M+347.0%
2019$3.31M+27.4%
2018$2.60M-